Delivery Order SPE2DR25D3004-SPE2DR26FXRM9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,484.37 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 45 mg capsules (unit dose, 10-count packaging) with a completion date of December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,201.74 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsule unit dose packages (10s) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used to treat and prevent influenza, representing a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,747.48 for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 count. This is a firm fixed-price delivery order with no set-aside designation, awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used for influenza...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,288.91 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. The contract is a firm fixed-price arrangement with a completion date of December 19, 2025, and carries no set-aside designation, indicating it was awarded through competitive procurement. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,235.68 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit-dose packages of 10 units. This firm fixed price delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a pediatric or adult antiviral medication used primarily for influenza treatment and prophylaxis. The contract was competitively awarded without set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $2,995.68 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The award was issued on December 3, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,497.84 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit-dose packaging (10-count). This is a firm fixed price delivery order with no set-aside designation, issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRM9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,914.04 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 30 mg capsules in unit-dose packages of ten on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used for influenza treatment and prophylaxis, making this a critical pharmaceutical supply for military healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements for critical pharmaceutical commodities across multiple therapeutic domains in support of military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/21/25 |